Cullinan Therapeutics, Inc.
Status: Publicly traded
Direct answer
Cullinan Therapeutics, Inc. is publicly traded on NASDAQ under the ticker CGEM.
Cullinan Therapeutics, Inc. operates as a biopharmaceutical firm actively advancing its therapeutic candidates through clinical trials. This company is focused on developing innovative treatments primarily for cancer, including those that leverage the immune system (immuno-oncology). Its current roster of investigational drugs comprises CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. Patrick A....
Can you invest in Cullinan Therapeutics, Inc.?
Yes. Cullinan Therapeutics, Inc. is publicly traded on NASDAQ under the ticker CGEM.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Cullinan Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.